OBJECTIVE: To test the hypothesis that intravenous infusion of lipid would bring about changes in adipose tissue metabolism, which would tend to spare net fat mobilization, and to attempt to identify the mediators of such responses. DESIGN: The triacylglycerol (TG) emulsion, Intralipid, was infused and metablic changes in subcutaneous adipose tissue and forearm muscle were assessed by measurements of arterio-venous differences. SUBJECTS: Six normal male subjects aged 21 ± 37 y, with body mass index (BMI) 23.0 ± 25.9 kgam 2 . RESULTS: Plasma TG and non-esteri®ed fatty acid (NEFA) concentrations rose during infusion as expected. The rise in systemic plasma NEFA concentration occurred despite decreased NEFA release from adipose tissue. Intralipid infusion resulted in a suppression of intracellular lipolysis in adipose tissue, by mechanisms which are not clear. Plasma leptin concentrations, measured in a search for the regulator of lipolysis, showed consistent leptin release from adipose tissue which did not change signi®cantly with time. CONCLUSION: The suppression of intracellular lipolysis in adipose tissue during Intralipid infusion is a new observation and may re¯ect a novel mechanism for regulation of fat storage.
Introduction
Since the body's fat store is the ultimate repository for excess dietary energy, there must be a close relationship between the processes of fat deposition and fat mobilization, and whole-body energy balance. The factors regulating fat storage and mobilization in adipose tissue in the postabsorptive and postprandial states are becoming clearer. 1 ± 3 Regulation of adipose tissue metabolism in the postprandial period appears to involve not only hormonal and metabolic signals, but also changes in blood¯ow. 4, 5 It is not clear how this closely integrated system would respond to the introduction of lipid energy via an intravenous route, when many of the normal regulatory features would presumably be absent. However, patients fed intravenously with lipid-based feeding regimens, may show accumulation of body fat, despite protein catabolism, 6 so there must be mechanisms by which the regulation of fat balance is maintained. We therefore hypothesised that during intravenous infusion of a lipid emulsion, changes in adipose tissue metabolism would occur which would resemble those observed in the postprandial state, in the sense that net fat mobilization would be spared. The physiological mediators would probably be quite different, however, from those operating after meals.
In order to investigate the regulation of fat balance during intravenous infusion of a triacylglycerol (TG) emulsion, we have studied subcutaneous adipose tissue and forearm muscle metabolism during infusion of the TG emulsion Intralipid (Pharmacia Ltd, Milton Keynes, UK). Unexpectedly we found that intracellular lipolysis (catalysed by hormone-sensitive lipase, HSL) was suppressed when we infused the exogeneous lipid emulsion. To investigate this unexpected ®nding further, we also measured leptin production across subcutaneous adipose tissue because of the putative role of this hormone in regulating energy balance, and the recent discovery that leptin may exert feedback stimulation of adipose tissue lipolysis. 7 ± 9 Glycerol concentrations in this study have been reported previously in a different context, 10 and some of the other data have been presented in abstract form. 11 
Methods

Subjects and protocol
The studies were approved by the Central Oxford Research Ethics Committee and all subjects gave informed consent. Six normal, healthy male subjects aged 21±37 y, with body mass index (BMI) 23.0± 25.9 kgam 2 , ate a low-fat evening meal and were studied the next morning after an overnight fast.
A catheter (22 gauge Â 10 cm, Secalon Hydrocath, Ohmeda, Swindon, UK) was introduced over a guide wire, into a small vein on the abdominal wall and advanced until its tip lay near, but superior to, the inguinal ligament. As described previously, 12, 13 blood obtained from such a vein has all the characteristics expected of the venous drainage from adipose tissue. A cannula was inserted retrogradely into a vein draining a hand which was warmed in a box with an air temperature of 65 C to provide arterialized blood.
14 A further cannula was placed retrogradely into an antecubital vein draining deep forearm tissues on the contralateral arm. Another antecubital cannula was placed on the arm with the warmed hand for infusion. Cannulae were kept patent by slow infusion of saline; no heparin was used.
Subcutaneous . Blood samples were withdrawn at 30 min intervals for 2 h and then hourly. The infusion was continued for 4 h and then further blood samples were taken at 30 min intervals over the next 90 min.
Analytical methods
Blood samples were taken into heparinized syringes and a sample immediately deproteinized with perchloric acid for enzymatic estimation of wholeblood glycerol, lactate and 3-hydroxybutyrate (3-OHB) concentrations, as described previously. 18 The remaining plasma was separated rapidly at 4 C. A portion was kept for estimation of glucose concentration and the remainder was stored in aliquots at 720 C.
Plasma concentrations of glucose, non-esteri®ed fatty acid (NEFA) and TG, were estimated with enzymatic methods adapated to an IL Monarch centrifugal analyzer (Instrumentation Laboratory (UK) Ltd, Warrington, UK). Plasma leptin concentrations were measured with a commercially available human leptin radioimmunoassay (RIA) kit (Linco Research Inc, St Charles, MD) using 100 ml plasma, in accordance with the manufacturer's instructions. Plasma insulin concentrations were measured with a RIA kit (Pharmacia AB, Uppsala, Sweden).
Calculation and statistical methods
Calculations were as described in detail previously. 2 Flux of a substrate across a tissue was calculated as the product of arterialized-venous difference (referred to for simplicity as arterio-venous difference below) and blood¯ow. For calculation of substrate¯uxes, concentrations of NEFA, TG and leptin in plasma were converted to those in whole blood using the haematocrit. The extraction of TG across adipose and forearm tissues was assumed to represent the action of lipoprotein lipase (LPL). The rate of action of HSL (intracellular lipolysis) in adipose tissue was calculated as the (outward) transcapillary¯ux of glycerol, that is, the difference between total glycerol release and that assumed to arise from the action of LPL. Assumptions involved in this calculation have been discussed in detail previously. 2, 19 In the present experiments, there are some potential dif®culties with these assumptions. Systemic glycerol concentrations rose during Intralipid infusion to around 250± 300 mmolal and in the forearm there was a tendency for glycerol to move into the tissue to equilibrate with tissue water. 10 This may have reduced net glycerol ef¯ux even in adipose tissue and this could contribute to an under-estimation of HSL action. This is considered further in the Discussion. Another assumption untested in this situation is that the hydrolysis of plasma TG by LPL is complete (that is, there is no production of mono-or di-acylglycerol). We have previously shown this to be true in states of high LPL action such as combined high-fat meal and insulin infusion, 20, 21 but it was not tested in the present study. Therefore, there is a possibility that the action of LPL was under-estimated during Intralipid infusion.
Changes in concentrations with time, and arteriovenous differences across the tissues, were assessed by repeated-measures analysis of variance (ANOVA) using time and site (arterialized, forearm venous and adipose venous) as within-subjects factors. Arteriovenous differences were analysed over the three separate experimental periods: basal (730, 0 min), during Intralipid infusion (30±240 min) and after Intralipid infusion (270±330 min). Substrate¯uxes and the rate of HSL action were averaged for each person within the three experimental periods, and compared using repeated-measures ANOVA, and 
Results
Arterialized and venous concentrations
Arterialized plasma TG concentrations rose during Intralipid infusion, to a peak value of almost 5 mmolal at 240 min, and then declined sharply after the infusion was stopped (Figure 1 ). There were signi®cant arterio-venous differences for TG across both forearm and adipose tissue in the fasting state, presumed to re¯ect LPL action (mean AE s.e.m., mmolal: arterialized 1117AE171; forearm venous 1101AE170; adipose venous 1089AE173). However, TG arterio-venous differences were not signi®cant across either tissue, during or after Intralipid infusion.
Arterialized NEFA concentrations also rose during Intralipid infusion, to a value at 240 min almost twice the baseline concentration ( Figure 1 ). They fell after infusion to a value similar to baseline at 330 min.
Adipose venous NEFA concentrations were more than twice the arteralized values in the fasting state, as usually found, but remained almost steady during Intralipid infusion, with the result that NEFA ef¯ux decreased (see below). As there was no net NEFA release across the forearm, metabolite exchange across this tissue is not considered further.
In previous studies, we have observed a close relationship between arterialized plasma NEFA concentrations and veno-arterial differences for NEFA across the subcutaneous adipose depot, in a variety of physiological conditions. 13, 22 An unusual feature of the present results was that this relationship was lost completely (Figure 2) .
Glycerol concentraitons in arterialized and deep forearm venous blood in these studies were reported previously. 10 Like NEFA concentrations, adipose venous glycerol concentrations in the fasting state were around three times the arterialized values, but remained steady during Intralipid infusion (not shown).
Arterialized plasma glucose concentrations rose slightly but signi®cantly during Intralipid infusion, whereas insulin concentrations were constant throughout the study (Figure 3) . Arterialized blood lactate concentrations were almost constant, whereas 3-hydroxybutyrate concentrations rose sharply during Intralipid infusion (Figure 3 ). Both fell after the infusion was discontinued (Figure 3) .
Plasma leptin concentrations were measured on ®ve subjects. There was consistent release of leptin from adipose tissue throughout the study (Figure 4 ). Mean Adipose tissue TG extraction did not change signi®-cantly during or after Intralipid infusion, compared with baseline ( Figure 5 ). In contrast, NEFA ef¯ux from adipose tissue decreased considerably during Intralipid infusion, and decreased still further when Intralipid infusion was discontinued ( Figure 5 ). Glycerol ef¯ux also decreased during and after Intralipid infusion ( Figure 5 ). The calculated rate of intracellular lipolysis (HSL action) in adipose tissue fell during Intralipid infusion and, like net NEFA ef¯ux, decreased yet further after Intralipid infusion was discontinued ( Figure 5) .
The median ratio of NEFA to glycerol release from adipose tissue in the fasting state was 3.40, during Intralipid infusion 3.01, and after discontinuation of Intralipid infusion was 3.18. None of these values was signi®cantly different from 3.00 (P b 0X17 by Wilcoxon signed-rank test). 
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Adipose tissue and forearm blood¯ow
Adipose tissue and forearm blood¯ows did not change during Intralipid infusion or after its discontinuation (Table 1) .
Discussion
The elevation of systemic plasma TG, NEFA and 3-OHB concentrations, in response to Intralipid infusion, were as expected. Although the removal of both long-chain TG emulsions and mixed medium-chain TG and long-chain TG emulsions has been studied previously across the forearm, 23 ± 25 this was the ®rst study to investigate the removal of Intralipid across subcutaneous adipose tissue, and our results were surprising in several respects.
First, the extraction of TG in the presence of Intralipid was much less than might have been expected, compared with our previous observations in lean, healthy subjects when the TG concentration is elevated by ingestion of a fatty meal.
1,2,26 Fractional extraction of chylomicron-TG across adipose tissue after a fatty meal peaks at around 40% and extraction of total plasma TG 15%, in healthy subjects following a meal. 1 There is evidence that Intralipid particles in the circulation rapidly acquire the apolipoproteins necessary for removal, 27, 28 and it has been assumed that their clearance re¯ects that of chylomicron-TG (reviewed in Ref. 29) , although the half-life in the circulation is greater than that of chylomicrons. 30 Our results, in contrast, suggest that removal is not mainly by LPL-mediated TG hydrolysis in peripheral tissues. This view is borne out by recent observations on the metabolism of TG emulsions compared with chylomicrons in rats. 29 Our study involved a small number of subjects, and the lack of demonstration of signi®-cant extraction of plasma TG across the tissues almost certainly re¯ects a lack of precision to measure small arteriovenous differences against a high arterial`background', in other words, a type II statistical error. Nevertheless, the difference from previous studies with fat ingestion is clear.
It must be remembered, however, that our previous observations on chylomicron-TG clearance were made in the postprandial state when adipose tissue LP may be activated by insulin. 19, 31 Therefore removal in adipose tissue might have been greater if, in addition, insulin had been given. Against, this, Chen et al 32 infused Liposyn 20% at 246 mmol TG.kg
71
.h 71 (against 210 mmol TG.kg 71 .h 71 in our studies) during infusion of insulin, to raise the plasma insulin concentration ®fteen-fold, and found greater elevation of plasma TG concentrations (0.74± 6.05 mmolal) than in the present studies. Another possible explanation for the lower than expected TG extraction, could be the lack of increase in adipose tissue blood¯ow during Intralipid infusion. Subcutaneous abdominal adipose tissue blood¯ow rises several-fold in lean subjects given a fatty meal. 4 As a result of this absence of adipose tissue blood¯ow stimulation, there would be decreased delivery of Intralipid particles to adipose tissue and, therefore, decreased TG clearance compared to the situation after a meal.
The second respect in which our results were unexpected, concerns the effect of Intralipid infusion on endogeneous (intracellular) lipolysis in adipose tissue. Total net release of NEFA from adipose tissue, decreased signi®cantly during Intralipid infusion and decreased yet further after Intralipid infusion was discontinued. This re¯ected decreased intracellular lipolysis, as shown by the calculated rate of HSL action. We have no ready explanation for this decline in intracellular lipolysis. Plasma insulin concentrations, a major regulator of HSL, did not change measurably throughout the study, although we cannot rule out a subtle, undetectable change; lipolysis is exquisitely sensitive to insulin. 33 Another possibility is that the availability of fatty acids from an extracellular source in some way signalled for a suppression of HSL activity, as there is evidence that fatty acids and their CoA esters can inhibit HSL activity, at least in cell-free systems. 34 However, this does not explain why intracellular lipolysis continued to be suppressed after infusion when plasma NEFA concentrations were falling rapidly. A third possible explanation is that the elevated blood 3-OHB concentrations provided the signal to decrease lipolysis. There is clear evidence for a marked anti-lipolytic effect of 3-OHB from studies in which it was infused, albeit to conserably higher blood concentrations than achieved here. 35 We fully accept that our observations can only be regarded as preliminary and that there is a need for control studies, for instance in which glycerol alone is infused and in which the relative contributions of elevation of TG and NEFA concentrations are distinguished. However, we have shown previously that continued fasting over this period results in a steady increase in intracellular lipolysis with increasing arterialized plasma NEFA concentrations. 22 We also accept that, as discussed in Methods, there is potential for under-estimation of HSL action during Intralipid infusion because of the movement of glycerol into the tissues down a concentration gradient. Despite this, we are con®dent about the suppression of intracellular lipolysis, because of the marked reduction in net NEFA ef¯ux from adipose tissue.
It is well recognised that the systemic plasma NEFA concentration will rise during Intralipid infusion, even without accompanying heparin infusion. 32, 36 The additional NEFA presumably arise from the hydrolysis of Intralipid particles by LPL in peripheral tissues and this is borne out by the change in the composition of the NEFA pool during infusion of exogeneous TG emulsions. 37 However, in these studies the systemic plasma NEFA concentration rose, despite decreased net NEFA release from adipose Figure 2 ). Systemic plasma NEFA concentrations were therefore considerably higher during Intralipid infusion than would be predicted from their rate of release from adipose tissue. There are two possible explanations. One is that additional NEFA were released from sources outside adipose tissue and muscle. We cannot say from the present results from where these additional NEFA may have arisen, but one possibility would be intravascular lipolysis by LPL released into the circulation. 36 The alternative explanation would be that NEFA clearance is impaired during Intralipid infusion. We know of no other evidence for this, but it could represent saturation of hepatic pathways of fatty acid esteri®cation and oxidation. The rapid rise in blood 3-OHB concentration suggests a considerable increase in the rate of hepatic fatty acid oxidation.
We measured plasma leptin concentrations in a search for the putative signal which decreased HSL activity during Intralipid infusion, in view of increasing evidenced that leptin production is regulated by nutrient availability, 38 that certain variants of the leptin receptor are expressed on adipocytes 39 and that leptin itself is a stimulator of lipolysis. 8, 9 Our results con®rm consistent leptin release by human adipose tissue in vivo, only observed previously in the fasting state 40 or after carbohydrate ingestion. 41 Although there was no signi®cant change in leptin secretion during Intralipid infusion, in keeping with the suggestion that nutrient availability or insulin exert relatively slow effects on leptin expression, 42 the numbers studied are small and these results should be treated only as preliminary. In summary, we have shown suppression of intracellular lipolysis in subcutaneous adipose tissue during infusion of Intralipid. The signal for this reduction in lipolysis was not identi®ed, but the response is compatible with the view that adipocyte TG content is highly regulated in accordance with whole-body energy balance. The result is that adipose tissue TG content is preserved during Intralipid infusion (as opposed to the continued mobilization which would occur in fasting). However, this occurs not primarily by stimulation of the uptake of TGfatty acids, but by sparing of endogeneous TG stores. Elucidation of the signal which brings about this linkage of whole-body energy balance with regulation of adipocyte TG stores, could be of great interest in understanding the regulation of body fat content.
